Health In Tech, Inc.(HIT)— Stock Profile, AI Score & Financials

Financials · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Health In Tech, Inc. (HIT) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. 13F Pro's AI-powered ranking engine scores HIT at 38.7/100 on a 32-signal composite quality model, placing it at rank #2,181 of 2,962 stocks — the bottom half of the AI-ranked universe. HIT scores in the top quartile across institutional flow (97.8), revenue growth (85.3). Areas of concern include earnings quality (4.5) and revenue scale (5.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 25.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Health In Tech, Inc. reports quarterly revenue of $8.1M, net income of $-2.5M. Top institutional holders of HIT by reported 13-F value include Whetstone Capital Advisors, Mink Brook Asset Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HIT trades on the Nasdaq exchange and files with the SEC under CIK 2019505. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Health In Tech, Inc. directly from SEC EDGAR.